Pro Medicus Limited
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiol… Read more
Pro Medicus Limited (PMCUF) - Net Assets
Latest net assets as of December 2025: $388.77 Million USD
Based on the latest financial reports, Pro Medicus Limited (PMCUF) has net assets worth $388.77 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($533.70 Million) and total liabilities ($144.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $388.77 Million |
| % of Total Assets | 72.84% |
| Annual Growth Rate | 18.08% |
| 5-Year Change | 214.59% |
| 10-Year Change | 838.33% |
| Growth Volatility | 17.74 |
Pro Medicus Limited - Net Assets Trend (1999–2025)
This chart illustrates how Pro Medicus Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pro Medicus Limited (1999–2025)
The table below shows the annual net assets of Pro Medicus Limited from 1999 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $256.96 Million | +36.88% |
| 2024-06-30 | $187.73 Million | +35.27% |
| 2023-06-30 | $138.78 Million | +36.41% |
| 2022-06-30 | $101.73 Million | +24.54% |
| 2021-06-30 | $81.68 Million | +35.72% |
| 2020-06-30 | $60.18 Million | +22.10% |
| 2019-06-30 | $49.29 Million | +40.55% |
| 2018-06-30 | $35.07 Million | +0.67% |
| 2017-06-30 | $34.83 Million | +27.20% |
| 2016-06-30 | $27.39 Million | +24.83% |
| 2015-06-30 | $21.94 Million | +5.94% |
| 2014-06-30 | $20.71 Million | -1.20% |
| 2013-06-30 | $20.96 Million | +30.98% |
| 2012-06-30 | $16.00 Million | +5.29% |
| 2011-06-30 | $15.20 Million | -9.67% |
| 2010-06-30 | $16.82 Million | +4.22% |
| 2009-06-30 | $16.14 Million | +2.53% |
| 2008-06-30 | $15.74 Million | +10.43% |
| 2007-06-30 | $14.26 Million | +7.96% |
| 2006-06-30 | $13.21 Million | +3.03% |
| 2005-06-30 | $12.82 Million | +15.74% |
| 2004-06-30 | $11.07 Million | +3.04% |
| 2003-06-30 | $10.75 Million | +44.23% |
| 2002-06-30 | $7.45 Million | +44.98% |
| 2001-06-30 | $5.14 Million | +55.57% |
| 2000-06-30 | $3.30 Million | -3.11% |
| 1999-06-30 | $3.41 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pro Medicus Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6940.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $239.46 Million | 93.19% |
| Common Stock | $34.73 Million | 13.52% |
| Other Comprehensive Income | $-17.23 Million | -6.71% |
| Total Equity | $256.96 Million | 100.00% |
Pro Medicus Limited Competitors by Market Cap
The table below lists competitors of Pro Medicus Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Flughafen Zuerich AG
LSE:0RG6
|
$5.58 Billion |
|
Shenzhen Techwinsemi Technology Co. Ltd.
SHE:001309
|
$5.58 Billion |
|
ESAB Corp
NYSE:ESAB
|
$5.58 Billion |
|
Mineral Resources Ltd
AU:MIN
|
$5.58 Billion |
|
Leo Group Co Ltd
SHE:002131
|
$5.55 Billion |
|
Piraeus Financial Holdings S.A
AT:TPEIR
|
$5.54 Billion |
|
Isuzu Motors Limited
PINK:ISUZF
|
$5.54 Billion |
|
HDFC Asset Management Company Limited
NSE:HDFCAMC
|
$5.53 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pro Medicus Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 187,728,000 to 256,963,000, a change of 69,235,000 (36.9%).
- Net income of 115,217,000 contributed positively to equity growth.
- Dividend payments of 49,114,000 reduced retained earnings.
- Share repurchases of 7,853,000 reduced equity.
- Other comprehensive income decreased equity by 16,496,000.
- Other factors increased equity by 27,481,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $115.22 Million | +44.84% |
| Dividends Paid | $49.11 Million | -19.11% |
| Share Repurchases | $7.85 Million | -3.06% |
| Other Comprehensive Income | $-16.50 Million | -6.42% |
| Other Changes | $27.48 Million | +10.69% |
| Total Change | $- | 36.88% |
Book Value vs Market Value Analysis
This analysis compares Pro Medicus Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 42.76x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3079.18x to 42.76x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-06-30 | $0.03 | $105.00 | x |
| 2000-06-30 | $0.03 | $105.00 | x |
| 2001-06-30 | $0.05 | $105.00 | x |
| 2002-06-30 | $0.07 | $105.00 | x |
| 2003-06-30 | $0.11 | $105.00 | x |
| 2004-06-30 | $0.11 | $105.00 | x |
| 2005-06-30 | $0.13 | $105.00 | x |
| 2006-06-30 | $0.13 | $105.00 | x |
| 2007-06-30 | $0.14 | $105.00 | x |
| 2008-06-30 | $0.16 | $105.00 | x |
| 2009-06-30 | $0.16 | $105.00 | x |
| 2010-06-30 | $0.17 | $105.00 | x |
| 2011-06-30 | $0.15 | $105.00 | x |
| 2012-06-30 | $0.16 | $105.00 | x |
| 2013-06-30 | $0.21 | $105.00 | x |
| 2014-06-30 | $0.21 | $105.00 | x |
| 2015-06-30 | $0.21 | $105.00 | x |
| 2016-06-30 | $0.26 | $105.00 | x |
| 2017-06-30 | $0.33 | $105.00 | x |
| 2018-06-30 | $0.34 | $105.00 | x |
| 2019-06-30 | $0.47 | $105.00 | x |
| 2020-06-30 | $0.58 | $105.00 | x |
| 2021-06-30 | $0.78 | $105.00 | x |
| 2022-06-30 | $0.97 | $105.00 | x |
| 2023-06-30 | $1.33 | $105.00 | x |
| 2024-06-30 | $1.79 | $105.00 | x |
| 2025-06-30 | $2.46 | $105.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pro Medicus Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 44.84%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 54.12%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 1.32x
- Recent ROE (44.84%) is above the historical average (38.25%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 36.42% | 0.00% | 0.00x | 1.52x | $901.00K |
| 2000 | 99.61% | 0.00% | 0.00x | 2.10x | $2.96 Million |
| 2001 | 79.49% | 40.91% | 1.07x | 1.82x | $3.57 Million |
| 2002 | 64.57% | 47.38% | 0.89x | 1.53x | $4.07 Million |
| 2003 | 42.30% | 49.96% | 0.73x | 1.17x | $3.47 Million |
| 2004 | 32.30% | 45.28% | 0.60x | 1.18x | $2.47 Million |
| 2005 | 42.85% | 53.45% | 0.67x | 1.20x | $4.21 Million |
| 2006 | 46.30% | 54.12% | 0.73x | 1.17x | $4.79 Million |
| 2007 | 49.46% | 56.24% | 0.71x | 1.23x | $5.63 Million |
| 2008 | 50.39% | 86.63% | 0.47x | 1.24x | $6.36 Million |
| 2009 | 35.20% | 57.17% | 0.45x | 1.36x | $4.07 Million |
| 2010 | 23.30% | 20.42% | 0.80x | 1.43x | $2.24 Million |
| 2011 | 3.31% | 3.60% | 0.60x | 1.52x | $-1.02 Million |
| 2012 | 11.19% | 15.83% | 0.49x | 1.45x | $190.80K |
| 2013 | 24.48% | 46.00% | 0.38x | 1.40x | $3.04 Million |
| 2014 | 7.29% | 10.58% | 0.49x | 1.41x | $-561.70K |
| 2015 | 14.66% | 18.39% | 0.58x | 1.37x | $1.02 Million |
| 2016 | 23.25% | 23.14% | 0.70x | 1.44x | $3.63 Million |
| 2017 | 26.76% | 29.50% | 0.67x | 1.36x | $5.84 Million |
| 2018 | 28.42% | 29.42% | 0.55x | 1.74x | $6.46 Million |
| 2019 | 38.80% | 38.17% | 0.59x | 1.71x | $14.20 Million |
| 2020 | 38.34% | 40.61% | 0.59x | 1.59x | $17.06 Million |
| 2021 | 37.77% | 45.45% | 0.54x | 1.54x | $22.68 Million |
| 2022 | 43.69% | 47.55% | 0.60x | 1.54x | $34.27 Million |
| 2023 | 43.70% | 48.56% | 0.62x | 1.46x | $46.77 Million |
| 2024 | 44.10% | 51.27% | 0.63x | 1.37x | $64.02 Million |
| 2025 | 44.84% | 54.12% | 0.63x | 1.32x | $89.52 Million |
Industry Comparison
This section compares Pro Medicus Limited's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $25,622,845
- Average return on equity (ROE) among peers: -162.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pro Medicus Limited (PMCUF) | $388.77 Million | 36.42% | 0.37x | $5.57 Billion |
| Accolade, Inc. (ACCD) | $390.85 Million | -12.96% | 0.22x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $80.90 Million | -180.10% | 1.78x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-6.40 Million | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-728.00K | 0.00% | 0.00x | $1.88 Million |
| Alternate Health Corp (AHGIF) | $1.36 Million | -129.15% | 0.71x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $-1.77 Million | 0.00% | 0.00x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $1.09 Million | -1305.34% | 0.76x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-71.11K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $-204.41 Million | 0.00% | 0.00x | $79.04 Million |